Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09KTN
|
|||
| Former ID |
DNC012757
|
|||
| Drug Name |
Asp-D-Glu-Leu-Glu-Cha-Cys
|
|||
| Synonyms |
CHEMBL303541; Asp-D-Glu-Leu-Glu-Cha-Cys; AC1LAAJ7; BDBM50096402; Asp-D-Glu-Leu-Glu-Cha(beta-cyclohexylanine)-Cys; L-Asp-D-Glu-L-Leu-L-Glu-3-Cyclohexyl-L-Ala-L-Cys-OH; (R)-2-[(S)-2-((S)-2-{(S)-2-[(R)-2-((S)-2-Amino-3-carboxy-propanoylamino)-4-carboxy-butanoylamino]-4-methyl-pentanoylamino}-4-carboxy-butanoylamino)-3-cyclohexyl-propanoylamino]-3-mercapto-propionic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C32H52N6O13S
|
|||
| Canonical SMILES |
CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)N
|
|||
| InChI |
1S/C32H52N6O13S/c1-16(2)12-21(36-28(46)19(8-10-24(39)40)34-27(45)18(33)14-26(43)44)30(48)35-20(9-11-25(41)42)29(47)37-22(13-17-6-4-3-5-7-17)31(49)38-23(15-52)32(50)51/h16-23,52H,3-15,33H2,1-2H3,(H,34,45)(H,35,48)(H,36,46)(H,37,47)(H,38,49)(H,39,40)(H,41,42)(H,43,44)(H,50,51)/t18-,19+,20-,21-,22-,23-/m0/s1
|
|||
| InChIKey |
ZFRKNLVWQDBGEY-ZKPZVSKHSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis C virus NS3 helicase (HCV NS3) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain. Bioorg Med Chem Lett. 2001 Jan 22;11(2):203-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.